Topics:

Eliglustat has a better safety profile than the existing approved oral drug for type 1 Gaucher disease, and is easier to take than enzyme replacement therapy.

Given the greater frequency of depression than manic episodes in bipolar disorder, what clues indicate bipolar disorder rather than unipolar depression?

Studies looking at add-on treatment with SGLT2 inhibitors have found their effects on glycemic control to be roughly additive. Here, a concise look at results of clinical trial results plus guidance on renal dose adjustment.

A new international multicenter study of often-deadly macrophage activation syndrome in systemic JIA reveals key laboratory and clinical warning signs. Watch ferritin levels especially closely.

The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.

Physicians face a wide variety of exposures beyond medical malpractice claims including both labor and tax claims for misclassified contractors.

Polycystic ovary syndrome, “dermatoses of pregnancy,” systemic sclerosis, subacute cutaneous lupus erythematosus, gallbladder agenesis, sarcoidosis—a close look at medical problems seen frequently in women.

As the digital space continues to change, medical practices must change their marketing approaches as well.

Here are two key areas where CMS could make adjustments to home health regulations that would benefit not just home health, but the industry in general.

Pages

Subscribe to Cancer Network RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.